Lipigon Pharmaceuticals AB (publ) (FRA:9RP)
Germany flag Germany · Delayed Price · Currency is EUR
0.0010
0.00 (0.00%)
At close: Jan 23, 2026

FRA:9RP Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
11516-
Market Cap Growth
-57.05%-69.52%241.44%-76.67%--
Enterprise Value
-11302-
Last Close Price
0.000.000.030.050.42-
PS Ratio
5.791.663.32-28.61-
PB Ratio
0.512.211.924.132.76-
P/TBV Ratio
0.512.211.924.132.76-
EV/Sales Ratio
-0.621.78-10.68-
Asset Turnover
0.070.430.74-0.100.44
Quick Ratio
5.801.966.431.534.496.01
Current Ratio
5.962.076.511.554.546.75
Return on Equity (ROE)
-214.35%-139.56%-75.06%-281.03%-228.75%-106.49%
Return on Assets (ROA)
-118.45%-69.50%-37.84%-118.44%-117.98%-53.00%
Return on Capital Employed (ROCE)
-245.60%-346.90%-47.30%-985.10%-183.60%-60.30%
Earnings Yield
-471.38%-147.59%-22.26%-235.76%-64.99%-
FCF Yield
-372.64%-146.14%-26.28%-234.27%-55.99%-
Buyback Yield / Dilution
-135.65%-115.86%-336.30%-63.10%-104.09%-1.84%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.